POSITION PAPER: General considerations on rapid desensitization for drug hypersensitivity a consensus statement
نویسندگان
چکیده
General considerations on rapid desensitization for drug hypersensitivity – a consensus statement J. R. Cernadas* , K. Brockow* , A. Romano* , W. Aberer , M. J. Torres , A. Bircher , P. Campi , M. L. Sanz , M. Castells, P. Demoly & W. J. Pichler , for the European Network of Drug Allergy and the EAACI interest group on drug hypersensitivity Department of Allergy and Clinical Immunology, Medical University, H. S. João, Porto, Portugal; Department of Dermatology und Allergology Biederstein, Division Environmental Dermatology and Allergology Helmholtz Zentrum Munchen/TUM, Technical University Munich, Munich, Germany; Allergy Unit, C.I. Columbus, Rome and IRCCS Oasi Maria S.S., Troina, Italy; Department of Dermatology, Medical University of Graz, Graz, Austria; Research Unit for Allergic Diseases, Allergy Service, Carlos Haya Hospital, Malaga, Spain; Allergy Unit, Department of Dermatology, University Hospital, Basel, Switzerland; Allergy Clinic, Azienda Sanitaria di Firenze, Florence, Italy; Department of Allergology and Clinical Immunology, University Clinic, University of Navarra, Pamplona, Spain; Department of Medicine, Division of Rheumatology, Immunology, and Allergy, Brigham and Women’s Hospital, and the Department of Medical Oncology, Dana Farber Cancer Institute, Boston, MA, USA; Exploration des Allergies, Maladies Respiratoires, INSERM U657, Hopital Arnaud de Villeneuve, University Hospital of Montpellier, Montpellier, France; Clinic for Rheumatology and Clinical Immunology/Allergology, Inselspital, Bern, Switzerland
منابع مشابه
General considerations on rapid desensitization for drug hypersensitivity - a consensus statement.
Drug hypersensitivity reactions can occur with most drugs, are unpredictable, may affect any organ or system, and range widely in clinical severity from mild pruritus to anaphylaxis. In most cases, the suspected drug is avoided in the future. However, for certain patients, the particular drug may be essential for optimal therapy. Under these circumstances, desensitization may be performed. Drug...
متن کاملRapid desensitization for hypersensitivity reactions to chemotherapeutic drugs; a case series
Usage of cancer chemotherapeutics drugs can be associated with adverse drug reactions. When IgE-mediated drug reactions are formed following administration of a chemotherapeutic drug that is a drug of choice, drug desensitization protocols can be helpful. Hypersensitivity reactions can be allergic or nonallergic, but the clinical manifestations are similar. Rapid drug desensitization (RDD) is e...
متن کاملRapid desensitization for hypersensitivity reactions to chemotherapeutic drugs; a case series
Usage of cancer chemotherapeutics drugs can be associated with adverse drug reactions. When IgE-mediated drug reactions are formed following administration of a chemotherapeutic drug that is a drug of choice, drug desensitization protocols can be helpful. Hypersensitivity reactions can be allergic or nonallergic, but the clinical manifestations are similar. Rapid drug desensitization (RDD) is e...
متن کاملRapid desensitization in delayed hypersensitivity reactions to chemotherapy and monoclonal antibodies
Background Drug desensitization is the induction of temporary clinical unresponsiveness to drug antigens to which patients have presented severe hypersensitivity reactions (HSR). Rapid desensitization in patients suffering immediate hypersensitivity reactions with chemotherapeutic agents and monoclonal antibodies have been widely described and have shown to be successful. Non-immediate hypersen...
متن کاملSuccessful Desensitization of a Patient with Rituximab Hypersensitivity
Rituximab is a monoclonal antibody which targets CD20 in B cells that is used for the treatment of CD20 positive oncologic and hematologic malignancies. Rituximab causes hypersensitivity reactions during infusions. The delay of treatment or loss of a highly efficient drug can be prevented by rapid drug desensitization method in patients who are allergic to rituximab. We report a low grade B cel...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
دوره شماره
صفحات -
تاریخ انتشار 2010